scispace - formally typeset
C

Charles E. Alpers

Researcher at University of Washington

Publications -  418
Citations -  35650

Charles E. Alpers is an academic researcher from University of Washington. The author has contributed to research in topics: Renal pathology & Glomerulonephritis. The author has an hindex of 89, co-authored 409 publications receiving 32440 citations. Previous affiliations of Charles E. Alpers include New York Medical College & University of Washington Medical Center.

Papers
More filters
Book ChapterDOI

Membranoproliferative Glomerulonephritis and C3 Glomerulopathy

TL;DR: This work has shown that although light microscopy may appear similar in these entities, immunofluorescence findings with staining for immunoglobulin and complement and corresponding deposits by electron microscopy readily allow recognition of the immune complexes in MPGN.
Book ChapterDOI

Other Diseases with Organized Deposits

TL;DR: The lesion known as fibrillary glomerulonephritis is characterized by the accumulation of fibrils that are roughly 10 to 20 nm in diameter and are throughout the mesangial matrix and basement membranes in a manner very similar to amyloid.
Journal ArticleDOI

Early Transplant Arteriopathy in Kidney Transplantation.

TL;DR: Early transplant arteriopathy (ETA) as discussed by the authors is characterized by endothelial cell swelling and intimal edema but without the intimal arteritis that defines vascular rejection, which raises the specter of active rejection processes that require medical intervention.
Book ChapterDOI

Experimental Models of Mixed Cryoglobulinemia

TL;DR: The thymic stromal lymphopoietin transgenic mouse model of type III mixed cryoglobulinemia is used to test the importance of the inhibitory Fc receptor FcRllb in limiting the severity of disease expression, in demonstrating the deleterious effect of infiltrating monocyte/macrophage populations that is a characteristic feature of this type of glomerulonephritis, and in demonstrating its potential reversibility with appropriate therapeutic interventions.